Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion type Assertion NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_head.
- NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion description "[ZQNK-29 is a well characterized premature human NK/T-cell lymphoma cell line with expression of the B-cell marker CD20 and will provide a useful pre-clinic model for characterization and potential therapeutic studies of the aggressive NK/T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_provenance.
- NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion evidence source_evidence_literature NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_provenance.
- NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion SIO_000772 26299072 NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_provenance.
- NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion wasDerivedFrom befree-2016 NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_provenance.
- NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion wasGeneratedBy ECO_0000203 NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_provenance.